Pharmakokinetik von Linezolid bei Dialyse (pharmacokinetics of linezolid under dialysis) - LINUS
Phase 1
- Conditions
- acute renal failure and infection or sepsis without acute renal failure
- Registration Number
- EUCTR2006-002338-39-DE
- Lead Sponsor
- niversitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
- The receipt of linezolid in the normal treatment of care
- acute renale failure with a dialysis-therapy or sepsis without acute renale failure
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- hypersensivity against linezolid
- newborn, children, adolescent, pregnant women, nursing women, pre-menopausal women
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: pharmacokinetic of Linezolid under dialysis;Secondary Objective: influence of sepsis alone without dialysis;Primary end point(s): no end points because it is only an accompanying pharmocokinetic-study
- Secondary Outcome Measures
Name Time Method